Diabetics Rejoice: MannKind’s Insulin Inhaler Afrezza’s FDA-Approved


MannKind's inhaler insulin Afrezza gained F.D.A. approval, Friday, June 27. Andrew Pollack of the New York Times offers a lot of good news for insulin-dependent diabetics in "Afrezza, a New...